Hylomorph Overview
- Founded
- 2015

- Status
- Private
- Employees
- 10

- Latest Deal Type
- Series B
- Latest Deal Amount
- $6.61M

- Investors
- 11
Hylomorph General Information
Description
Provider of healthcare biomaterials intended to optimize the interface between implantable medical devices and biological tissues. The company's bio-engineered implants prevent postoperative complications in implantable medical devices such as fibrosis, infection, migration, deploys advanced methods combining biotech and surface micro-engineering to promote optimal interaction between human tissues and foreign implants and first indication for use in cardiac pacemakers and defibrillators, and neurostimulators, enabling users to improve the quality of life of patients and the quality of care by healthcare professionals.
Contact Information
- Technoparkstrasse 1
- 8005 Zurich
- Switzerland
Hylomorph Timeline
Hylomorph Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series B) | 06-Dec-2021 | $6.61M | 000.00 | 000.00 | Completed | Clinical Trials - General |
7. Accelerator/Incubator | 31-Jan-2020 | 00.000 | Completed | Clinical Trials - General | ||
6. Secondary Transaction - Private | 00.000 | Completed | Clinical Trials - General | |||
5. Early Stage VC (Series A) | 14-Sep-2018 | 00.000 | 00.000 | 000.00 | Completed | Clinical Trials - General |
4. Accelerator/Incubator | 00.000 | 00000 | Completed | Startup | ||
3. Accelerator/Incubator | 000.00 | 00000 | Completed | Startup | ||
2. Early Stage VC | 22-Aug-2016 | $114K | $114K | 00.000 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
Hylomorph Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Ordinary | 111,111 | $0.108338 | $1.08 | $1.08 | 1x | $1.08 | 4.81% |
Hylomorph Comparisons
Industry
00000
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialHylomorph Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ACell | Formerly VC-backed | Columbia, MD | 000 | 000.00 | 000000&0 | 000.00 |
00000 000000000 | Formerly PE-Backed | Silver Spring, MD | 000 | 00000 | 000000000 | 00000 |
Hylomorph Executive Team (6)
Hylomorph Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Aldo Ferrari | Hylomorph | Chief Scientific Officer & Board Member | 000 0000 |
Gian-Luigi Berini | Hylomorph | Chairman | 000 0000 |
Peter Gabriel | Self | Board Member | 000 0000 |
Simone Bottan Ph.D | Hylomorph | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Hylomorph Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHylomorph Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Geneva Funds | Mutual Fund | Minority | 000 0000 | 000000 0 | |
Geneva Smart Invest | Venture Capital | Minority | 000 0000 | 000000 0 | |
Startup Angel Network | Angel Group | Minority | 000 0000 | 000000 0 | |
European Commission | Government | 000 0000 | 000000 0 | ||
StartAngels Network | Angel Group | Minority | 000 0000 | 000000 0 |